Key result
Continuous-pump heparin therapy monitored by activated coagulation time resulted in successful responses in 132 of 134 patients (98.5%) with venous thrombosis or pulmonary embolism.
Why the study?
Does continuous-pump heparin therapy monitored by activated coagulation time (ACT) effectively treat venous thrombosis or pulmonary embolism?
Population
134 patients with venous thrombosis or pulmonary embolism, confirmed by radiological techniques
Design
Cohort
Authors
Loading...
May support ACT-monitored heparin for VTE; hypothesis-generating and should not yet change practice.
Observational (n=134)
Does continuous-pump heparin therapy monitored by activated coagulation time (ACT) effectively treat venous thrombosis or pulmonary embolism?
A protocol of continuous-pump heparin therapy monitored by activated coagulation time (ACT) is successful and safe for treating venous thromboembolism when followed closely.
Paul G. Hattersley (1983) conducted an observational in Venous thrombosis or pulmonary embolism (n=134). Continuous-pump heparin therapy monitored by activated coagulation time (ACT) was evaluated on Response to therapy (no heparin failures). Continuous-pump heparin therapy monitored by activated coagulation time resulted in successful responses in 132 of 134 patients (98.5%) with venous thrombosis or pulmonary embolism.